Gastroesophageal Reflux Disease Therapeutics Market Outlook For 2026–2030 Covering Growth Drivers And Industry Trends
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Gastroesophageal Reflux Disease Therapeutics Market Expected To Scale Between 2026 And 2030?
The gastroesophageal reflux disease therapeutics market size has seen significant expansion in recent years. It is anticipated to increase from $6.08 billion in 2025 to $6.42 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.6%. The historical growth of this market stemmed from the escalating prevalence of GERD, the adoption of proton pump inhibitors, growing awareness concerning digestive health, the expansion of hospital pharmacies, and an enlarging geriatric population.
The gastroesophageal reflux disease therapeutics market is expected to exhibit robust expansion over the next few years. It is projected to achieve a size of $8.38 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.9%. The market’s growth during this forecast period can be attributed to advancements in drug formulations, the increasing prevalence of e-pharmacies, the adoption of telemedicine for gastro care, heightened investment in precision medicine, and a rising demand for minimally invasive therapies. Significant trends for the forecast period include personalized GERD treatment approaches, the development of novel drug delivery systems, an escalating demand for over-the-counter GERD medications, an amplified focus on gut health and microbiome regulation, and the integration of remote patient monitoring along with telehealth solutions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12058&type=smp
What Key Factors Are Shaping The Gastroesophageal Reflux Disease Therapeutics Market Landscape?
The increased practice of self-medication is a major factor boosting the expansion of the gastroesophageal reflux disease therapeutics market. This involves individuals treating their own medical conditions with drugs or other substances, independent of professional medical advice. It is instrumental in recognizing and avoiding dietary triggers, managing stress, and ceasing smoking, all of which substantially alleviate GERD symptoms. A notable example is the July 2024 report by the Proprietary Association of Great Britain (PAGB), a UK-based trade association, which indicated that given 64 million UK residents had at least one self-treatable condition in 2023, the percentage of cases where GPs recommended over-the-counter self-care significantly increased from 58% in 2023 to 75% in 2024. Furthermore, consumer trust in these medications grew to 89%, marking an 8-point gain from the prior year. Consequently, the widespread use of self-medication is a key propeller for the gastroesophageal reflux disease therapeutics market.
How Is The Gastroesophageal Reflux Disease Therapeutics Market Broken Down By Segment Categories?
The gastroesophageal reflux disease therapeutics market covered in this report is segmented –
1) By Type: Branded, Generic
2) By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class
3) By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Supermarkets
Subsegments:
1) By Branded: Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists, Antacids, Coating Agents
2) By Generic: Generic Proton Pump Inhibitors (PPIs), Generic H2-Receptor Antagonists, Generic Antacids, Generic Coating Agents
Which Trends Are Impacting The Progress Of The Gastroesophageal Reflux Disease Therapeutics Market?
Major companies within the gastroesophageal reflux disease therapeutics market are focusing on creating innovative systems, such as wireless pH-capsule reflux testing systems. These medical devices are specifically designed for the diagnosis and ongoing monitoring of gastroesophageal reflux disease (GERD) and related health issues. For instance, in April 2023, Laborie Medical Technologies Corp., a US-based firm that manufactures medical testing equipment, unveiled its new alpHaONE system. This wireless pH-capsule reflux testing system is particularly engineered to diagnose gastroesophageal reflux disease (GERD). The system is capable of monitoring data for up to 96 hours, providing precise and trustworthy information. The alpHaONE system offers a distinct solution, characterized by an ergonomic and compact form, easy-to-press enlarged buttons, and a secure capsule delivery mechanism designed to safeguard the patient’s esophagus.
Which Players Are Present In The Gastroesophageal Reflux Disease Therapeutics Market Space?
Major companies operating in the gastroesophageal reflux disease therapeutics market are Pfizer Inc., Johnson and Johnson, Novartis AG, Sanofi S.A., AstraZeneca plc, GlaxoSmithKline plc, Eisai Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries, Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, CHEPLAPHARM Arzneimittel GmbH, Daewoong Pharmaceutical Co. Ltd, Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Camber Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., RaQualia Pharma Inc, TWi Pharmaceuticals Inc., Astellas Pharma Inc., SFJ Pharmaceuticals Group, Boehringer Ingelheim International GmbH, Cadila Pharmaceuticals Limited
Get The Full Gastroesophageal Reflux Disease Therapeutics Market Report:
Which Region Accounts For The Largest Portion Of The Gastroesophageal Reflux Disease Therapeutics Market?
North America was the largest region in the gastroesophageal reflux disease therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroesophageal reflux disease therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gastroesophageal Reflux Disease Therapeutics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Gastroesophageal Reflux Disease Therapeutics Market 2026, By The Business Research Company
Gastroesophageal Reflux Disease Therapeutics Market Report 2026
Animal Gastroesophageal Reflux Disease Market Report 2026
Reflux Testing Products Market Report 2026
https://www.thebusinessresearchcompany.com/report/reflux-testing-products-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
